Headquartered in La Jolla, California, Innovus Pharma (OTCQB: INNV) is an emerging pharmaceutical company that develops, in-licenses, acquires and markets proprietary pharmaceutical products in sexual dysfunction, pain, and respiratory diseases.

The Company generates revenues from its lead products for , desire and satisfaction, and for . Innovus has an additional two marketed products in this space including Sensum+ (for sales outside the U.S. only), for loss of penile sensitivity due to circumcision, and Glide, a high viscosity low molarity water based lubricant.

The company’s management team has a proven track record in product acquisition, development, commercial partnership and commercialization.